Ultrasound-guided OCT proves able to ID breast tumors

Ultrasound-guided optical coherence tomography (OCT) appears to be an effective means for differentiating early-stage breast cancers from benign lesions, according to researchers at the University of Connecticut in Storrs.1 As such, it has the potential to reduce the number of breast biopsies women undergo for suspicious lesions.

Diffuse optical tomography measures light absorption within the tissue at two optical wavelengths to quantify blood content (hemoglobin levels). Since cancerous lesions tend to have many more blood vessels than normal tissue, hemoglobin levels can help distinguish malignant from benign lesions. Working to determine the effectiveness of the approach, Quing Zhu and colleagues examined data on 178 women undergoing biopsy on solid lesions via ultrasound with a near-infrared (NIR) imager. The device uses a traditional handheld ultrasound probe to pinpoint suspicious masses in the breast and near-infrared lighting projected through a series of optical fibers around the probe's periphery to penetrate and characterize the mass once it is found. The infrared light can penetrate tissue up to four centimeters.

The researchers measured light absorption at two wavelengths to compute total hemoglobin concentrations (tHb), and correlated those measurements with results from biopsy. Their efforts revealed 114 benign lesions and 61 carcinomas. Maximum and average tHb were significantly higher in the malignant group, and the technique produced the best results (sensitivity at 92% and specificity at 93%) for cancers less than 2 cm.

The approach "holds promise as an adjunct to mammography and ultrasound for distinguishing early-stage invasive breast cancers from benign lesions," Zhu says. "We expect this technology will be used to help radiologists evaluate small to intermediate size lesions that are harder to diagnose with conventional imaging technologies."

1. Q. Zhu et al., Radiology 256: 367-378 (2010)

More BioOptics World Current Issue Articles
More BioOptics World Archives Issue Articles

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Johnson & Johnson to acquire ophthalmic device maker Abbott Medical Optics for $4.33B

The acquisition will include Abbott's ophthalmic products in cataract surgery, laser refractive surgery, and consumer eye health.

Third FDA-approved study supports additional potential use of laser ablation technology

The FDA has approved an additional Investigational Device Exemption (IDE) to evaluate the NeuroBlate laser ablation system.

Contract to provide U.S. Armed Forces access to laser procedure for gum tissue regeneration

The U.S. Armed Forces will have access to a laser procedure for fully regenerating gum tissues lost to disease.

Avinger signs agreement with HealthTrust for OCT image-guided atherectomy system

HealthTrust will acquire Avinger's Pantheris OCT image-guided atherectomy system that recently received FDA approval.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS